Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Ching

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Medicine|September 8, 2020
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialRobert J Motzer, Paul B Robbins, Thomas Powles, et al.
Cancer Discovery|June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted TherapyAlexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Nature Communications|December 3, 2020
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcomeYeon Hee Park, Samir Lal, Jeong Eon Lee, et al.
Cancer Immunology Research|August 11, 2021
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor ImmunityYuanming Xu, Lucia Campos Carrascosa, Yik Andy Yeung, et al.
Nature Immunology|December 30, 2025
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumorsThomas N Burn, Jan Schröder, Luke C Gandolfo, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumoursThomas N Burn, Jan Schröder, Luke C Gandolfo, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Medicine|September 8, 2020
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialRobert J Motzer, Paul B Robbins, Thomas Powles, et al.
Cancer Discovery|June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted TherapyAlexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Nature Communications|December 3, 2020
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcomeYeon Hee Park, Samir Lal, Jeong Eon Lee, et al.
Cancer Immunology Research|August 11, 2021
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor ImmunityYuanming Xu, Lucia Campos Carrascosa, Yik Andy Yeung, et al.
Nature Immunology|December 30, 2025
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumorsThomas N Burn, Jan Schröder, Luke C Gandolfo, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumoursThomas N Burn, Jan Schröder, Luke C Gandolfo, et al.
Pageof 3